rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1997-11-19
|
pubmed:abstractText |
The authors' objective is to identify MAGE-1 tumor antigen in clinical melanoma specimens and to verify the extent of its expression in tumors where evidence of specific gene transcripts can be obtained.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0014-312X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
403-10
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9323494-Antibodies, Monoclonal,
pubmed-meshheading:9323494-Antigens, Neoplasm,
pubmed-meshheading:9323494-Genetic Variation,
pubmed-meshheading:9323494-Humans,
pubmed-meshheading:9323494-Immunoblotting,
pubmed-meshheading:9323494-Immunohistochemistry,
pubmed-meshheading:9323494-Melanoma,
pubmed-meshheading:9323494-Melanoma-Specific Antigens,
pubmed-meshheading:9323494-Neoplasm Proteins,
pubmed-meshheading:9323494-Polymerase Chain Reaction,
pubmed-meshheading:9323494-Transcription, Genetic
|
pubmed:year |
1997
|
pubmed:articleTitle |
Heterogeneity of melanoma antigen-1 (MAGE-1) gene and protein expression in malignant melanoma.
|
pubmed:affiliation |
Department of Surgery, University of Basel, Switzerland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|